Key Points:
1. HSPCs are recruited to Staphylococcus aureus infected skin wounds, differentiate into neutrophils and hasten resolution of infection.
.
Bacterial sensing via TLR2 elicits PGE 2 production in HSPC that provides autocrine positive feedback to meet the local demand for granulopoiesis.
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Introduction
Polymorphonuclear cells (PMNs) are first-line effector cells of the innate immune system recruited to a bacterial nidus. They are produced in the bone marrow (BM) by hematopoietic stem and progenitor cells (HSPCs), which undergo compensatory granulopoiesis when mature PMNs rapidly exit BM to traffic to the site of bacterial infection 1 . However, mounting evidence suggests that HSPCs themselves may contribute to the innate immune response. HSPCs consist of a heterogeneous population of cells, which include rare quiescent hematopoietic stem cells (HSCs), and larger numbers of multipotent and highly proliferative early progenitor cells that express high levels of c-kit and Sca-1 and are the source of common myeloid progenitors (CMPs), which possess more limited proliferative capacity and expand to phagocytes.
Inflammation elicits HSPC mobilization from BM and recruitment to sites of tissue injury 2, 3, 4 , prompting the current study on the role of HSPCs in the innate immune response to cutaneous infection.
HSPCs traffic to S. aureus-infected skin wounds where they differentiate to PMNs 3 .
Though the majority of PMNs enter wounds from the circulation as mature cells, we recently reported that up to 20% are derived locally from HSPCs and contribute to host defense and bacterial clearance 3 . HSPCs collected from S. aureus-infected wounds formed three-fold more granulocyte colonies than those harvested from uninfected wounds 3 , suggesting that the granulopoietic potential of HSPCs is responsive to signals encountered in the presence of an infection. Previous studies have shown that HSPCs can detect and respond to bacteria through Toll-like receptors (TLRs) that recognize pathogen-associated molecular patterns 5 . In particular, TLR2 is activated by S. aureus lipopeptides, lipoteichoic acid and peptidoglycan 6 . Triggering TLR2 on HSPCs leads to signaling via MyD88, the common adaptor protein used by all TLRs
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HSPCs express all known prostaglandin E 2 (PGE 2 ) receptors and exogenous PGE 2 enhances HSPC survival and entry into cell cycle after ex vivo incubation 9 . PGE 2 is rapidly metabolized in vivo by prostaglandin dehydrogenase and may act in an autocrine or paracrine manner to activate transcription and control post-transcriptional gene expression 10, 11 
Material and Methods

Mice
Male and female mice 8-16 weeks old on a C57BL/6 genetic background were used in all the experiments. All animal experiments were approved by Institutional Animal Care and Use
Committee of the University of California at Davis and performed following the guidelines of Animal Welfare Act and Health Research Extension Act.
Mouse model of S. aureus wound infection
Skin wounds were created and inoculated with S. aureus as described previously 15 and in Supplemental Methods.
Preparation of bioluminescent S. aureus and non-invasive quantification of wound EGFP-PMN
and bioluminescent bacteria S. aureus was cultured and prepared as previously described 15 and in Supplemental Methods.
Actively metabolizing bacteria and EGFP-PMN fluorescence at wound sites over time were quantified using the Xenogen IVIS 100 imaging system and Living Image 2.5 software (Caliper Life Science), as described previously 3, 15 .
Immuno-depletion of c-kit + HSPC
HSPC depletion was performed as previously described 3 and in Supplemental Methods. 
In vitro proliferation of HSPCs
Statistical Analysis
Data analysis was performed using GraphPad Prism version 5.0 (GraphPad Software). Here, we set out to determine the impact of depletion of HSPCs on the cellular composition in S. aureus-infected skin wounds. After antibody depletion, wound PMN numbers in HSPCdepleted mice were decreased 42-50% over 7 days, a much larger reduction in PMN number than can be explained by antibody-mediated BM depletion alone ( Figure 1A ). Taking into account the 30% reduction in BM PMNs available for trafficking to the wound following treatment, we estimate that 28% of the PMNs in the wound were derived by local HSPC differentiation. 
TLR2 and MyD88 are essential for HSPC granulocytic differentiation in S. aureus inoculated skin wounds
The adaptor molecule MyD88 is necessary for optimal recruitment of PMNs to S. aureusinfected wounds where it mediates intracellular signaling in response to activation of TLR and IL-1R family members 14, 17, 18 . Since HSPCs express TLRs on their surface 5 , we examined the role of MyD88 and TLR2 in HSPC proliferation and granulocytic differentiation after wounding and infection. We first examined signaling of myeloid expansion in LSK cells from WT mice. A dose-dependent effect of the TLR2 agonist Pam 3 CSK 4 on PMN production was observed at 96
hours of ex vivo culture of LSK cells. At day 7, this resulted in a 50-fold expansion that was specific for myeloid cell production dependent upon TLR2 signaling (Supplemental Figure 5 ).
Mice lacking MyD88 or TLR2 exhibited normal numbers of HSPCs in BM and peripheral blood (Supplementary Figure 6 ). In contrast, LSK cell numbers in S. aureus-inoculated wounds of TLR2-or MyD88-deficient mice trended lower but were not significantly different from WT mice, however, far fewer of their progeny including CMPs, promyelocytes, and PMNs were detected in the abscess ( Figure 3B ).
We next examined whether local HSPC differentiation to granulocytes is dependent on signaling via a TLR2/MyD88 pathway. Bead-enriched HSPCs harvested from S. aureusinoculated WT mice were significantly increased compared with the numbers of HSPCs harvested from saline-treated wounds ( Figure 3C ). Interestingly, HSPCs harvested from both S.
aureus-inoculated and saline-treated wounds of TLR2-or MyD88-deficient mice formed substantially fewer granulocyte colonies ex vivo than HSPCs harvested from S. aureusinoculated and saline-treated wounds of WT mice (up to 75% decrease). This was not due to an inherent inability of the HSPCs from TLR2-or MyD88-deficient mice to undergo myeloid Figures 6A and 7) . Thus, granulopoiesis of HSPCs from TLR2 or MyD88-deficient mice is defective within the wound environment while relatively intact in BM.
TLR2/MyD88 signaling of HSPCs mediates their differentiation within S. aureus-infected wounds
HSPCs differentiate towards myeloid cells upon activation by TLR ligands in vitro 5, 19 , which led to the hypothesis that proliferation and myeloid differentiation at the site of infection was due to direct recognition of bacterial components by HSPCs, via TLR2 and MyD88, rather than through an indirect mechanism involving cytokines and growth factors present in the wound. Bone marrow from WT Lys-EGFP mice was enriched for HSPCs (and included ~4% LSK cells, or one-third the number of LSK recruited to S. aureus-inoculated wounds) and injected directly into infected wounds of WT, TLR2-deficient or MyD88-deficient mice. In these varied wound environments HSPCs expanded to PMNs equivalently, though there was a trend for less PMN production in MyD88-deficient wounds ( Figure 4A ). These data indicate that even in the absence of TLR2 or MyD88 signaling in the host cells within infected wounds, WT HSPCs adoptively-transferred in these knockouts can undergo normal granulocytic differentiation.
We next assessed whether HSPCs from TLR2-or MyD88-deficient mice could be induced to differentiate into PMNs when directly transferred to S. aureus-inoculated wounds of WT mice. HSPCs from WT Lys-EGFP produced more than twice as many PMNs than did Lys-
EGFP/MyD88
-/-HSPCs in response to S. aureus (p<0.001) ( Figure 4B ). In the absence of Lys- Figure 4C ).
To determine whether the differences in PMN production were due to activation of TLR2 alone, 
S. aureus-induced PGE 2 production via TLR2/MyD88 supports HSPC proliferation and granulopoiesis within wounds.
There are numerous downstream effector cytokines, chemokines and growth factors produced after activation of TLR2/MyD88 signaling that could contribute to HSPC proliferation within inflamed and infected tissue. PGE 2 is a key mediator of HSPC survival, proliferation, and homing to BM 9 , which lead to the hypothesis that PGE 2 plays a role in local PMN production from HSPCs within S. aureus inoculated wounds. BM HSPCs from WT mice increased their proliferation by 50% above baseline in vitro in response to heat-killed S. aureus as measured by BrdU incorporation ( Figure 6A ). This increase was abrogated by the addition of indomethacin , which blocks de novo PGE 2 production, indicating that enhanced HSPC proliferation in the presence of S. aureus was due to PGE 2 . As expected, S. aureus had no effect on proliferation of To confirm that TLR2 activation was sufficient to elicit the most proliferative HSPCs to produce PGE 2, FACS-sorted populations of LSK cells from WT, TLR2-or MyD88-deficient BM were incubated with or without the TLR2-specific agonist Pam 3 CSK 4 . WT LSK cells produced more than 100 ng/ml of PGE 2 in response to TLR2 activation, whereas TLR2-or MyD88-deficient LSK produced virtually none ( Figure 7A ). Finally, to determine whether PGE 2 itself Figure 7B ). These data reveal that PGE 2 is a key downstream product of TLR2/MyD88 signaling and is necessary and sufficient for expansion of LSK cells within cutaneous wounds.
Discussion
HSPCs cells can enter the circulation and traffic to sites of acute inflammation where they contribute to the innate immune response 20, [21] [22] 23 . The current study reveals a putative mechanism by which HSPCs traffic to cutaneous wounds, sense S. aureus and undergo extramedullary granulopoiesis that is necessary to effectively combat infection. TLR2 detection of pathogen triggers the activity of the adapter protein MyD88 and leads to production of PGE 2 .
This pathway appears to operate in an autocrine manner to signal HSPC expansion and myeloid proliferation during inflammation and infection based upon the following lines of evidence: 1)
Wounding in the presence of S. aureus elicited ~3-fold more HSPC expansion and PMN production in the wound than in the BM where granulopoiesis was amplified more due to inflammation than infection.
2) The presence of TLR2 and MyD88 was necessary for granulopoiesis in the wound in response to S. aureus since HSPCs lacking either the receptor or signaling adaptor exhibited defective PMN production, which was rescued by addition of PGE 2 .
3) LSK cells produce PGE 2 in a TLR2/MyD88-dependent fashion and locally differentiate and can expand PMN numbers solely by stimulation with PGE 2 . Thus the BM niche is dispensable
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We previously demonstrated that S. aureus infection of a full thickness cutaneous wound elicits local HSPC production of PMNs in which the extent of proliferation is proportional to the bacterial burden 3 . In the current study we demonstrate that depletion of HSPCs from the bone marrow by treatment with the anti-c-kit antibody ACK2 effectively diminished PMN in the abscess by 50%, which was accompanied by a two-fold increase in bacterial burden and a ~30% increase in wound size. By comparing systemic depletion of PMN by treatment with Gr-1, in the presence or absence of HSPC depletion using ACK2 3 , we estimate that ~30% of PMN in an abscess arise due to granulopoiesis and this process is critical to an effective innate immune response. We did not examine mature leukocyte counts in peripheral blood after infection, thus we do not know the effects of ACK2 antibody on parameters other than PMN in the wound during infection. It is unlikely that ACK2 exerts its effect through depletion of other leukocyte subsets and their influence on PMN trafficking since we and others have found that ACK2 treatment elicits insignificant reductions in total lymphocyte counts and a mild reduction in hematocrit 24, 25 .
PMN production in BM is controlled via a feedback mechanism in which homeostasis is regulated by G-CSF, as well as through TLR4 that can trigger its production in response to both neutropenia and during granulopoiesis to meet demand due to infection 26 . S. aureus signaled through TLR2/MyD88 to elicit a far more robust increase in the relative number of LSK, CMP, and promyelocytes in the abscess than in the BM. It is noteworthy that wounding and infection T cell production of IL-17 32 , which in turn induces G-CSF production in epithelial cells 33 . Interestingly, TLR2 signaling enhances myeloid differentiation of blood-derived HSCs far greater than BM-derived HSCs 3 . Thus, HSPCs mobilized in response to wounding-induced inflammatory mediators appear primed to respond to TLR2 stimulation and undergo granulopoiesis in the wound.
9
TLR2 is activated by components of gram-positive bacteria, which leads to upregulation of cytokines, chemokines, and proinflammatory mediators, including PGE 2 34 . PGE 2 modulates levels of TNF-α 35 , a negative regulator of HSPC proliferation 36 , as well as IL-6 37 , a pleiotropic cytokine that enhances entry into cell cycle 9 and hematopoiesis 38 . HSPC homing, survival, and proliferation is augmented after ex vivo incubation with PGE 2
.
Moreover, PGE 2 acts to expand HSC numbers and increase erythroid and granulocyte/monocyte colonies in a zebrafish model 39 .
Given the observed effects of PGE 2 on HSPC differentiation and its production by LSK cells after TLR stimulation, our data suggest that S. aureus-induced PGE 2 may serve as an autocrine signal that provides a feed-forward mechanism for enhancing local proliferation and granulopoiesis. Treatment of LSK cells from TLR2 or MyD88 knockout mice with PGE 2 effectively rescued the capacity to produce PMN even in the absence of bacterial infection in wounds of WT mice. Myeloid progenitors express inducible COX-1 40 . COX inhibition may not only elicit anti-inflammatory effects but may impact the contribution of HSPCs to wound healing. Rather than blocking eicosanoid production, targeting PGE 2 receptors may provide a more focused therapeutic effect. PGE 2 receptor agonists have been shown to improve healing and prevent ischemic injury in animal models 41, 42 . Further studies are warranted to determine the benefits and risks of using COX inhibitors or PGE 2 receptor agonists in the management of infected wounds.
In summary, these studies delineate an extramedullary immune function for HSPCs at the site of a S. aureus cutaneous infection. HSPCs trafficked from the BM to the site of infection where they were signaled via a pathway involving both TLR2 and MyD88 that promoted expansion from LSK cells and differentiation through CMP and promyelocytes into mature bactericidal PMNs. This response was linked to the production of PGE 2 that acted in an autocrine All data shown as Mean +/-SEM (*,p<0.05; **, p<0.01)
